SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXCH.L Regulatory News (XCH)

  • There is currently no data for XCH

Trading Statement

16 Dec 2009 07:00

RNS Number : 1806E
Xchanging PLC
16 December 2009
 

Pre-close trading statement

Xchanging, the global business processor, today updates the market ahead of entering its year end close period. 

Current trading

The Board expects results for the year ending 31 December 2009 to be in line with market expectations. Current trading conditions remain challenging; however, we continue to see significant pent up demand for outsourcing services as our customers look to reduce costs and investment.

Acceleration of lean processing strategy

Central to our success as a global business processor and our strategy to both grow existing platforms and add new ones, is our ability to be a cost competitive, lean processor with a uniform service offering. The Board has carried out a review into the progress we have made in the implementation of our lean processing strategy and has decided that it is appropriate and timely, given current market conditions, to accelerate elements of this strategy. This will be implemented by both reducing our onshore capacity in the UK and Germany and further increasing offshoring activities to India, leveraging the scale that Cambridge has provided to the Group. 

In the UK, we are looking to deliver efficiencies and synergies by combining operations and in Germany we will streamline capacity to ensure it is consistent with trading volumes, business support revenues and market needs. This will be carried out over the next six to eight months. The resulting transition of onshore workload and expertise to our operations in India will be implemented over a similar time frame to ensure processing continuity.

As a consequence, c. 250 roles will be removed and a further 230 positions will be offshored in 2010. These actions will lead to a reduction in annual costs of c. £14 million in 2010 with an anticipated full year run-rate benefit of c. £17million per annum from 2011 onwards. These changes are expected to be fully implemented by the middle of 2010 and will underpin our margin improvement plans for 2010 and 2011. We expect to take an exceptional charge of c. £17 million in 2009 to cover one-off costs.

Outlook

The Board is confident that the actions taken will underpin Xchanging's growth prospects. An element of the savings generated is being reinvested in global sales operations, which will further enhance Xchanging's ability to pursue and implement large contract wins and will prepare the company to take advantage of an uplift in the market. We remain confident that our expected plans for growth in 2010 will be delivered.

16 December 2009

Enquiries

Xchanging plc

David Andrews, Chief Executive Officer

Tel: +44 (0) 20 7780 6999

Richard Houghton, Chief Financial Officer

Cardew Group

Rupert Pittman

Tel: +44 (0) 20 7930 0777

David Roach

David Andrews and Richard Houghton will host a conference call for analysts and investors to discuss this pre-close trading statement at 09:00 BST on Wednesday, 16 December 2009. The conference call telephone number is +44 (0) 20 7162 0025, conference ID 853864. For individuals unable to participate in the conference call, a telephone replay will be available until Wednesday, 23 December 2009. Please telephone +44 (0) 20 7031 4064 (conference ID 853864).

The Group's full year results will be announced on Monday, 1 March 2010. 

About Xchanging

Xchanging is a global business processor with blue chip customers. We deliver procurement, HR, technology and mission-critical industry-specific processing services to customers in 42 countries. www.xchanging.com

Cautionary Statement: 

This announcement contains forward-looking statements that are based on current expectations or beliefs, as well as assumptions about future events. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as anticipate, target, expect, estimate, intend, plan, goal, believe, will, may, should, would, could, is confident, or other words of similar meaning. Undue reliance should not be placed on any such statements because they speak only as at the date of this document and, by their very nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results, and Xchanging's plans and objectives, to differ materially from those expressed or implied in the forward-looking statements.

There are a number of factors which could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among the factors that could cause actual results to differ materially from those described in the forward-looking statements are; increased competition, the loss of or damage to one or more key customer relationships, changes to customer ordering patterns, delays in obtaining customer approval or price level changes, the failure of one or more key suppliers, the outcome of business or industry restructuring, the outcome of any litigation, changes in economic conditions, currency fluctuations, changes in interest and tax rates, changes in raw material or energy market prices, changes in laws, regulations or regulatory policies, developments in legal or public policy doctrines, technological developments, the failure to retain key management, or the key timing and success of future acquisition opportunities or major investment projects.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTTABRTMMABBPL
Date   Source Headline
7th Apr 20157:00 amRNSMM4 amendment to earn-out terms
1st Apr 20152:06 pmRNSBlocklisting Interim Review
31st Mar 20154:54 pmRNSTotal Voting Rights
27th Mar 201511:09 amRNSDirector/PDMR Shareholding
24th Mar 20157:03 amRNSCMA provisional clearance
18th Mar 201511:48 amRNSDirector/PDMR Shareholding
18th Mar 201511:45 amRNSDirector/PDMR Shareholding
16th Mar 20159:46 amRNSDirector/PDMR Shareholding
11th Mar 20153:07 pmRNSTotal Voting Rights
5th Mar 20154:57 pmRNSHolding(s) in Company
3rd Mar 201510:58 amRNSDirector/PDMR Shareholding
27th Feb 20155:27 pmRNSDirector Declaration
26th Feb 20157:01 amRNSAcquisition
26th Feb 20157:01 amRNSFinal Results
13th Feb 20157:00 amRNSHolding(s) in Company
6th Feb 20157:00 amRNSAcquisition of Spikes Cavell
3rd Feb 20157:00 amRNSBlocklisting Interim Review
3rd Feb 20157:00 amRNSHolding(s) in Company
30th Jan 201511:43 amRNSHolding(s) in Company
27th Jan 20156:28 pmRNSHolding(s) in Company
23rd Dec 20143:01 pmRNSDirector/PDMR Shareholding
19th Dec 20147:00 amRNSAcquisition of Total Objects completed
9th Dec 20143:09 pmRNSTotal Objects Acquisition to Complete
5th Dec 20144:03 pmRNSDirector/PDMR Shareholding
4th Dec 20147:00 amRNSAgencyport CMA Referral
3rd Dec 20141:48 pmRNSHolding(s) in Company
2nd Dec 20143:14 pmRNSAgencyport CMA Update
27th Nov 201410:51 amRNSDirector/PDMR Shareholding
27th Nov 20147:00 amRNSInvestor Seminar
26th Nov 201412:46 pmRNSTotal Voting Rights
21st Nov 20141:01 pmRNSDirector Declaration
14th Nov 20147:51 amRNSWorkers' Compensation contract
6th Nov 20147:00 amRNSInterim Management Statement
3rd Nov 20145:12 pmRNSBlocklisting Interim Review
20th Oct 20142:59 pmRNSDirector/PDMR Shareholding
3rd Oct 201412:20 pmRNSBlocklisting Interim Review
1st Oct 20147:00 amRNSAgencyport CMA Order
24th Sep 20144:36 pmRNSDirector/PDMR Shareholding
17th Sep 201410:30 amRNSHolding(s) in Company
17th Sep 201410:21 amRNSHolding(s) in Company
29th Aug 201411:11 amRNSDirector/PDMR Shareholding
12th Aug 20145:21 pmRNSTotal Voting Rights
1st Aug 20141:04 pmRNSBlocklisting Interim Review
31st Jul 20147:00 amRNSHalf Yearly Report
30th Jul 20147:00 amRNSTakes full ownership of Fondsdepot Bank
14th Jul 20145:31 pmRNSHolding(s) in Company
8th Jul 20147:00 amRNSMM4 amendment to earn-out terms
4th Jul 20147:00 amRNSAcquisition
3rd Jul 20147:00 amRNSAcquisition
24th Jun 20145:16 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.